Ryner Lai

Researchers sought to better characterize the disease features, patient characteristics, and the effects of immunodeficiency on survival among patients with plasmablastic lymphoma.

Researchers sought to determine whether combination therapy with venetoclax and an anti-CD20 monoclonal antibody would improve outcomes in patients with CLL.

Researchers sought to evaluate long-term follow-up data among patients who have been prescribed BV-dacarbazine therapy among older individuals with untreated cHL.

Researchers determined use of a home pain monitoring app led to less clinically significant pain in children with cancer.

A substantial, long-lasting response can be achieved in patients with relapsed/refractory multiple myeloma (RRMM) using equecabtagene autoleucel (equel-cel).